tiprankstipranks
Decision Diagnostics Corp (DECN)
OTHER OTC:DECN
US Market
DECN
Decision Diagnostics
RESEARCH TOOLSreports

Decision Diagnostics (DECN) Ratios

86 Followers

Decision Diagnostics Ratios

DECN's free cash flow for Q3 2021 was $0.22. For the 2021 fiscal year, DECN's free cash flow was decreased by $ and operating cash flow was $-0.95. See a summary of the company’s cash flow.
Ratios
TTM
Dec 20Dec 19Dec 18Dec 17
Liquidity Ratios
Current Ratio
 0.33 0.33 0.27 0.58
Quick Ratio
 0.30 0.30 0.23 0.50
Cash Ratio
 0.11 0.11 0.02 0.13
Solvency Ratio
 -5.74 -5.74 -0.60 -0.72
Operating Cash Flow Ratio
 -0.29 -0.29 -0.22 -0.46
Short-Term Operating Cash Flow Coverage
 -0.48 -0.48 -0.36 -0.86
Net Current Asset Value
$ -3.54M$ -3.54M$ -3.89M$ -1.43M
Leverage Ratios
Debt-to-Assets Ratio
 0.52 0.52 0.53 0.37
Debt-to-Equity Ratio
 6.05 6.05 31.91 1.40
Debt-to-Capital Ratio
 0.86 0.86 0.97 0.58
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 11.69 11.69 60.57 3.83
Debt Service Coverage Ratio
 -0.08 -0.08 -0.02 -0.97
Interest Coverage Ratio
 -0.08 -0.08 -0.43 -4.80
Debt to Market Cap
 81.74 0.61 1.44 0.61
Interest Debt Per Share
 0.11 0.11 0.04 0.02
Net Debt to EBITDA
 -1.00 -1.00 -22.96 -0.63
Profitability Margins
Gross Profit Margin
25.18%25.18%35.74%13.74%
EBIT Margin
-121.55%-121.55%-4.91%-82.92%
EBITDA Margin
-121.55%-121.55%-4.91%-82.92%
Operating Profit Margin
-106.68%-106.68%-54.40%-82.88%
Pretax Profit Margin
-1499.05%-1499.05%-131.65%-100.19%
Net Profit Margin
-1499.05%-1499.05%-131.65%-100.19%
Continuous Operations Profit Margin
-1499.05%-1499.05%-131.65%-100.19%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
1405.14%1405.14%241.99%120.88%
Return on Assets (ROA)
-524.76%-524.76%-59.04%-53.51%
Return on Equity (ROE)
-10388.57%-6135.03%-3576.33%-205.13%
Return on Capital Employed (ROCE)
-289.77%-289.77%-389.11%-138.59%
Return on Invested Capital (ROIC)
-57.78%-57.78%-37.38%-64.62%
Return on Tangible Assets
-1221.39%-1221.39%-147.01%-90.75%
Earnings Yield
-111300.51%-618.34%-143.66%-89.62%
Efficiency Ratios
Receivables Turnover
 2.10 2.10 2.28 2.35
Payables Turnover
 0.87 0.87 1.22 1.87
Inventory Turnover
 9.22 9.22 9.18 7.69
Fixed Asset Turnover
 2.47 2.47 2.97 2.79
Asset Turnover
 0.35 0.35 0.45 0.53
Working Capital Turnover Ratio
 -0.57 -0.57 -0.99 -2.59
Cash Conversion Cycle
 -206.13 -206.13 -99.23 7.52
Days of Sales Outstanding
 174.05 174.05 160.34 155.04
Days of Inventory Outstanding
 39.61 39.61 39.78 47.44
Days of Payables Outstanding
 419.79 419.79 299.35 194.97
Operating Cycle
 213.66 213.66 200.12 202.49
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.10 1.07
Dividend Paid and CapEx Coverage Ratio
 -468.32K -468.32K -9.58 -14.65
Capital Expenditure Coverage Ratio
 -468.32K -468.32K -9.58 -14.65
Operating Cash Flow Coverage Ratio
 -0.48 -0.48 -0.40 -0.86
Operating Cash Flow to Sales Ratio
 -0.71 -0.71 -0.47 -0.59
Free Cash Flow Yield
-3925.93%-29.28%-56.46%-56.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -0.16 -0.70 -1.12
Price-to-Sales (P/S) Ratio
 0.02 2.42 0.92 1.12
Price-to-Book (P/B) Ratio
 0.06 9.92 24.89 2.29
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.03 -3.42 -1.77 -1.77
Price-to-Operating Cash Flow Ratio
 -0.02 -3.42 -1.96 -1.89
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 >-0.01 -0.04 0.03
Price-to-Fair Value
 0.06 9.92 24.89 2.29
Enterprise Value Multiple
 -1.01 -2.99 -41.64 -1.98
Enterprise Value
 2.44M 7.20M 4.86M 3.67M
EV to EBITDA
 -1.01 -2.99 -41.64 -1.98
EV to Sales
 1.23 3.64 2.04 1.64
EV to Free Cash Flow
 -1.74 -5.13 -3.95 -2.60
EV to Operating Cash Flow
 -1.74 -5.13 -4.36 -2.78
Tangible Book Value Per Share
 -0.01 -0.01 -0.02 >-0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 >-0.01
Revenue Per Share
 <0.01 <0.01 0.02 0.02
Net Income Per Share
 -0.11 -0.11 -0.02 -0.02
Tax Burden
 1.00 1.00 1.00 1.00
Interest Burden
 12.33 12.33 26.83 1.21
Research & Development to Revenue
 0.00 0.00 0.00 0.00
SG&A to Revenue
 1.17 1.17 0.73 0.97
Stock-Based Compensation to Revenue
 0.00 0.00 0.01 0.00
Income Quality
 0.05 0.05 0.36 0.59
Currency in USD